- Home
- POLA vs COEP Comparison
POLA vs COEP Comparison
Compare POLA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- COEP
- Stock Information
- Founded
- POLA 1979
- COEP 2017
- Country
- POLA United States
- COEP United States
- Employees
- POLA N/A
- COEP N/A
- Industry
- POLA Industrial Machinery/Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POLA Miscellaneous
- COEP Health Care
- Exchange
- POLA Nasdaq
- COEP Nasdaq
- Market Cap
- POLA 7.7M
- COEP 8.1M
- IPO Year
- POLA 2016
- COEP N/A
- Fundamental
- Price
- POLA $0.46
- COEP $0.20
- Analyst Decision
- POLA
- COEP
- Analyst Count
- POLA 0
- COEP 0
- Target Price
- POLA N/A
- COEP N/A
- AVG Volume (30 Days)
- POLA 161.1K
- COEP 268.8K
- Earning Date
- POLA 11-14-2024
- COEP 11-13-2024
- Dividend Yield
- POLA N/A
- COEP N/A
- EPS Growth
- POLA N/A
- COEP N/A
- EPS
- POLA N/A
- COEP N/A
- Revenue
- POLA $14,953,000.00
- COEP N/A
- Revenue This Year
- POLA $6.72
- COEP N/A
- Revenue Next Year
- POLA N/A
- COEP N/A
- P/E Ratio
- POLA N/A
- COEP N/A
- Revenue Growth
- POLA N/A
- COEP N/A
- 52 Week Low
- POLA $0.32
- COEP $0.15
- 52 Week High
- POLA $0.90
- COEP $1.33
- Technical
- Relative Strength Index (RSI)
- POLA 49.27
- COEP 48.99
- Support Level
- POLA $0.43
- COEP $0.19
- Resistance Level
- POLA $0.53
- COEP $0.22
- Average True Range (ATR)
- POLA 0.05
- COEP 0.02
- MACD
- POLA 0.00
- COEP -0.00
- Stochastic Oscillator
- POLA 45.07
- COEP 41.03
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.